Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan vs Amlodipine for ventricular remodeling in hypertensive patients with left ventricular hypertrophy
ChiCTR2000039291Phase 4Recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) and left ventricular hypertrophy (LVH) comparing Sacubitril/Valsartan with Amlodipine (2 arms). Primary endpoint: Left Ventricular Mass Index. Started Jul 2020; status: recruiting.
02
Drugs
sacubitril + valsartanamlodipine
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on ChiCTR2000039291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039291.